1990
DOI: 10.1128/mcb.10.2.705
|View full text |Cite
|
Sign up to set email alerts
|

Differentiation of mouse erythroleukemia cells is blocked by late up-regulation of a c-myb transgene.

Abstract: During chemically induced differentiation of Friend virus-infected mouse erythroleukemia (MEL) cell lines, there is a biphasic down-regulation of the c-myb proto-oncogene. A plasmid containing a murine c-myb cDNA controlled by a mouse metallothionein I promoter was transfected into the C19 MEL cell line. For six transfected clones, it was found that expression of the exogenous c-myb mRNA could be up-regulated by the addition of 120 FIM ZnCl2 and that the N,N'-hexamethylenebisacetamide-induced differentiation o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
89
0

Year Published

1992
1992
2006
2006

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 94 publications
(96 citation statements)
references
References 23 publications
7
89
0
Order By: Relevance
“…Curiously, M1/SCL cells were partially inhibited in their clonal suppression and di erentiation in response to LIF and Oncostatin-M but were indistinguishable from control M1 cultures when exposed to IL-6 (Tanigawa et al, 1995). Consistent with their e ects on M1 differentiation, constitutive expression of c-MYB and c-MYC also inhibited the di erentiation and growth arrest of murine erythroleukemia cells treated with DMSO (Coppola and Cole, 1986;Dmitrovsky et al, 1986;Prochownik and Kukowska, 1986;Clarke et al, 1988;McClinton et al, 1990). Based on these studies, one may speculate that the inappropriately high levels of c-MYC (and c-MYB, data not shown) mRNA expressed by M1.210 cells played a role in inhibiting cytokine-induced growth arrest.…”
Section: Discussionmentioning
confidence: 67%
“…Curiously, M1/SCL cells were partially inhibited in their clonal suppression and di erentiation in response to LIF and Oncostatin-M but were indistinguishable from control M1 cultures when exposed to IL-6 (Tanigawa et al, 1995). Consistent with their e ects on M1 differentiation, constitutive expression of c-MYB and c-MYC also inhibited the di erentiation and growth arrest of murine erythroleukemia cells treated with DMSO (Coppola and Cole, 1986;Dmitrovsky et al, 1986;Prochownik and Kukowska, 1986;Clarke et al, 1988;McClinton et al, 1990). Based on these studies, one may speculate that the inappropriately high levels of c-MYC (and c-MYB, data not shown) mRNA expressed by M1.210 cells played a role in inhibiting cytokine-induced growth arrest.…”
Section: Discussionmentioning
confidence: 67%
“…c-Myb is downregulated during HMBA induced differentiation and forced expression of c-Myb can block differentiation (Gonda and Metcalf, 1984;Marks et al, 1987;Clarke et al, 1988;McClinton et al, 1990). To develop a model that would allow the identification of Myb target genes, we have generated stable transfectants in the C19 MEL cell line that carry a dominant interfering Myb transgene (MEnT).…”
Section: Resultsmentioning
confidence: 99%
“…The C19 MEL cell line is a thymidine kinase-negative subclone of the 745 murine erythroleukemia cell line (McClinton et al, 1990) and was grown in Roswell Park Memorial Institute (RPMI)-1640 medium supplemented with 10% fetal bovine serum and 2 mM glutamine. Clone 17 cells are stable transfectants of the C19 MEL cell line that contain a dominant interfering Myb cDNA (MEnT) under the inducible transcriptional control of a mouse metallothionein I promoter and were cultured in the same medium containing G418 at a concentration of 400 mg/ml (Chen et al, 2002).…”
Section: Cell Culturementioning
confidence: 99%
See 2 more Smart Citations